Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Annals of Oncology

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/annonc/mdv548PMID 26578731
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.

  2015cited by this paper
• Randomized trial of TAS-102 for refractory metastatic colorectal cancer.

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2014cited by this paper
• A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/- targeted therapy.

  2014cited by this paper
• Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

  2014cited by this paper
• FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.

  2014cited by this paper
• Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study).

  2014cited by this paper
• Navigating later lines of treatment for advanced colorectal cancer - optimizing targeted biological therapies to improve outcomes.

  2014cited by this paper
• Metastatic pattern in colorectal cancer is strongly influenced by histological subtype.

  2014cited by this paper
• Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases.

  2013cited by this paper
• Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

  2013cited by this paper
• Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials.

  2012cited by this paper
• Risk of venous and arterial thromboembolic events associated with anti-EGFR agents: a meta-analysis of randomized clinical trials.

  2012cited by this paper
• A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial

  2012cited by this paper
• The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.

  2012cited by this paper
• Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability

  2011cited by this paper
• Modern insights into hepatic arterial infusion for liver metastases from colorectal cancer.

  2011cited by this paper
• Cetuximab plus FOLFIRINOX (ERBIRINOX) as first-line treatment for unresectable metastatic colorectal cancer: a phase II trial.

  2011cited by this paper
• Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis.

  2011cited by this paper
• Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial

  2010cited by this paper
• Prolonged Survival of Initially Unresectable Hepatic Colorectal Cancer Patients Treated With Hepatic Arterial Infusion of Oxaliplatin Followed by Radical Surgery of Metastases

  2010cited by this paper
• Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer

  2009cited by this paper
• Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma.

  2009cited by this paper
• Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy.

  2007cited by this paper
• Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.

  2007cited by this paper
• Hepatic Arterial Infusion of Oxaliplatin and Intravenous LV5FU2 in Unresectable Liver Metastases from Colorectal Cancer after Systemic Chemotherapy Failure

  2007cited by this paper
• Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

  2005cited by this paper
• Sample size tables for exact single‐stage phase II designs

  2001cited by this paper
• Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.

  1999cited by this paper
• Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy.

  1997cited by this paper

• Conversion treatment with hepatic arterial infusion of oxaliplatin, leucovorin and fluorouracil plus intravenous bevacizumab or cetuximab for initially unresectable colorectal liver metastasis: A prospective study.

  2026cites this paper
• Surgery for liver metastases

  2026cites this paper
• Retrospective Analysis of HAIP Therapy in Metastatic Colorectal Cancer: Efficacy, Safety, and Prognostic Factors

  2026cites this paper
• Hepatic Artery Infusion Pump Therapy in Unresectable and Resectable Liver Tumors.

  2026cites this paper
• Combination of Irreversible Electroporation and Clostridium novyi-NT Bacterial Therapy for Colorectal Liver Metastasis

  2025cites this paper
• Israel’s First Port-Based Hepatic Artery Infusion Program: Early Outcomes in Colorectal Liver Metastases

  2025cites this paper
• The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review

  2025influential citation
• Thermal ablation in the curative treatment of colorectal liver metastasis: new standard of care?—lessons learned from the COLLISION trial

  2025cites this paper
• Intra-arterial hepatic chemotherapy in metastatic colorectal cancer: differences between oxaliplatin-naive versus oxaliplatin-pretreated patients

  2025cites this paper
• Hepatic arterial infusion is effective in patients with unresectable colorectal liver metastases refractory to standard systemic chemotherapy: A retrospective cohort study

  2025cites this paper
• Surgical Management of Colorectal Cancer Liver Metastases.

  2025cites this paper
• Intraarterial Chemotherapy for Liver Metastases.

  2025cites this paper
• The Top Twenty-Five Most Influential Articles in Surgery for Colorectal Cancer.

  2025cites this paper
• Multimodal Treatment of Metastatic Rectal Cancer in a Young Patient: Case Report and Literature Review

  2024cites this paper
• Hepatic Artery Infusion Chemotherapy for Primary and Secondary Malignancies of the Liver: State of the Art and Current High-Level Evidence

  2024cites this paper
• Optimal Treatment Strategies for Borderline Resectable Liver Metastases from Colorectal Cancer.

  2024cites this paper
• INTRA-ARTERIAL CHEMOTHERAPY AS A CLINICAL OPTION FOR METASTATIC COLORECTAL CANCER: CONVERSION OF INOPERABLE LIVER METASTASES TO OPERABLE ILLUSTRATED WITH A CLINICAL CASE.

  2024cites this paper
• Hepatic Artery Infusion Pump Therapy in Unresectable and Resectable Liver Tumors

  2024cites this paper
• Oxaliplatin-induced peripheral neuropathy with hepatic arterial versus intravenous infusion in metastatic colorectal cancer

  2024cites this paper
• Safety and efficacy of percutaneous arterial port Implantation for Hepatic Arterial Infusion Chemotherapy

  2024cites this paper
• Crosstalk between Circadian Rhythm Dysregulation and Tumorigenesis, Tumor Metabolism and Tumor Immune Response

  2024cites this paper
• Challenges and Opportunities for Precision Surgery for Colorectal Liver Metastases

  2024cites this paper
• Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trial

  2024cites this paper
• Drug-eluting beads transcatheter arterial chemoembolization combined with systemic therapy versus systemic therapy alone as first-line treatment for unresectable colorectal liver metastases

  2024cites this paper
• American Radium Society Appropriate Use Criteria for the use of liver‐directed therapies for nonsurgical management of liver metastases: Systematic review and guidelines

  2023cites this paper
• Safety and feasibility of establishing an adjuvant hepatic artery infusion program.

  2023cites this paper
• Hepatic Artery Infusion Chemotherapy: A Quality Framework

  2023cites this paper
• Research Progress of Conversion Therapy in Colorectal Cancer Liver Metastasis

  2023cites this paper
• Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trial.

  2023cites this paper
• First-line Hepatic Artery Infusion for Unresectable CLM Works, but Will We Ever Get There?

  2023cites this paper
• Exploring a Novel Technique to Tackle the Shortage of Devices for Hepatic Arterial Infusion Chemotherapy: Early Results of an Alternate Approach for Percutaneous Arterial Port Catheter Placement

  2023cites this paper
• Management and pharmacotherapy of pediatric colorectal carcinoma: a review

  2023cites this paper
• "TIME" FOR OBESITY-RELATED CANCER: THE ROLE OF THE CIRCADIAN RHYTHM IN CANCER PATHOGENESIS AND TREATMENT.

  2023cites this paper
• Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatment.

  2022cites this paper
• Coil Embolization of Variant Hepatic Arteries During Percutaneous Arterial Port Catheter Placement for Intraarterial Chemotherapy: Analysis of Intrahepatic Perfusion Redistribution and Treatment Efficacy

  2022cites this paper
• Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†.

  2022cites this paper
• Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis

  2022cites this paper
• A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases

  2022cites this paper
• Synergizing liver systemic treatments with interventional oncology: friend or foe?

  2022cites this paper
• Impact of Preoperative Chemotherapy Features on Patient Outcomes after Hepatectomy for Initially Unresectable Colorectal Cancer Liver Metastases: A LiverMetSurvey Analysis

  2022cites this paper
• BRAF Mutations in Colorectal Liver Metastases: Prognostic Implications and Potential Therapeutic Strategies

  2022cites this paper
• A Critical Review of the Role of Local Therapy for Oligometastatic Gastrointestinal Cancer.

  2022cites this paper
• Research Progress on the Difference between Left and Right Colon Cancer

  2022cites this paper
• Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study

  2022cites this paper
• Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal Cancer

  2022influential citation
• Circadian rhythms and cancers: the intrinsic links and therapeutic potentials

  2022cites this paper
• Locoregional Liver-Directed Therapies to Treat Unresectable Colorectal Liver Metastases: A Review.

  2022cites this paper
• Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases

  2022cites this paper
• Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49.

  2022cites this paper
• Surgical Management of Colorectal Cancer Liver Metastases.

  2021cites this paper
• Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer

  2021cites this paper
• Review of Intra-Arterial Therapies for Colorectal Cancer Liver Metastasis

  2021influential citation
• Case Report: Cetuximab in Combination With Chemotherapy for the Treatment of Multifocal Hepatic Metastases From Colorectal Cancer Guided by Genetic Tests

  2021cites this paper
• Treatment sequencing of metastatic colorectal cancer based on primary tumor location.

  2021cites this paper
• Intra-arterial therapy for unresectable colorectal liver metastases: A meta-analysis.

  2021cites this paper
• Development and validation of survival nomograms in colorectal cancer patients with synchronous liver metastases underwent simultaneous surgical treatment of primary and metastatic lesions.

  2021cites this paper
• Defibrotide for Sinusoidal Obstruction Syndrome and Nodular Regenerative Hyperplasia After Oxaliplatin-Based Hepatic Intra-Arterial Chemotherapy: A Case Report.

  2021cites this paper
• The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer.

  2021cites this paper
• Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist

  2021cites this paper
• Minimizing the risk of small-for-size syndrome after liver surgery.

  2021cites this paper
• Kirsten rat sarcoma (KRAS) oncogene mutation predicts magnitude of response and outcomes in hepatic arterial infusion pump therapy of unresectable colorectal liver metastases.

  2021cites this paper
• Intraarterial Chemotherapy for Liver Metastases.

  2021cites this paper
• Transarterial Chemoembolisation and Combined Therapy

  2020cites this paper
• An appraisal of emerging second line therapies for metastatic colorectal cancer

  2020cites this paper
• Colorectal Cancer: Liver Metastatic Disease

  2020cites this paper
• Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study

  2020cites this paper
• The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis

  2020cites this paper
• Serum Gamma Glutamyl transferase is a predictor of recurrence after R0 hepatectomy for patients with colorectal cancer liver metastases

  2020cites this paper
• Immune-Modulating Effects of Conventional Therapies in Colorectal Cancer

  2020cites this paper
• The actual management of colorectal liver metastases.

  2020cites this paper
• Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement

  2020cites this paper
• Is intra-arterial hepatic chemotherapy painful?

  2020cites this paper
• A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer

  2020cites this paper
• Traitements des tumeurs malignes hépatiques guidés par l’imagerie

  2020cites this paper
• Optimizing circadian drug infusion schedules towards personalized cancer chronotherapy

  2020cites this paper
• Colorectal liver metastases: Current management and future perspectives

  2020cites this paper
• Adjuvant Hepatic Arterial Infusion Therapy

  2019cites this paper
• Complications of Intra-Arterial Regional Liver Therapy

  2019cites this paper
• Role of Hepatic Artery Infusion Pump Chemotherapy for Unresectable Colorectal Cancer Liver Metastases

  2019cites this paper
• Optimisation des stratégies thérapeutiques en radiologie interventionnelle : application en embolisation et en oncologie

  2019cites this paper
• Antitumour immunity invoked by hepatic arterial infusion of first‐line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8–12 years of follow‐up

  2019influential citation
• Hepatic metastasis from colorectal cancer.

  2019cites this paper
• The state of hepatic artery infusion chemotherapy in the management of metastatic colorectal cancer to the liver.

  2019cites this paper
• Chapter 4 Local Treatment Options for Unresectable Liver Metastases in Colorectal Cancer

  2019cites this paper
• Optimizing drug infusion schedules towards personalized cancer chronotherapy

  2019cites this paper
• Initial systemic chemotherapeutic and targeted therapy strategies for the treatment of colorectal cancer patients with liver metastases

  2019cites this paper
• Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases

  2019cites this paper
• Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study

  2019cites this paper
• Marking Disappearing Colorectal Liver Metastases After Complete Response to Neoadjuvant Chemotherapy via CT – A Pilot Study

  2019cites this paper
• Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver Metastases: A Review.

  2019cites this paper
• Regional therapies for the treatment of primary and metastatic hepatic tumors: A disease-based review of techniques and critical appraisal of current evidence.

  2019cites this paper
• Colorectal liver metastases: An update on multidisciplinary approach

  2019cites this paper
• Multidisciplinary approach of liver metastases from colorectal cancer

  2019cites this paper
• Oxaliplatin-Based Intra-Arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application

  2019cites this paper
• Systemic Therapy for Colorectal Cancer Liver Metastases: Sorting Through the Options

  2019cites this paper
• Pump-Based Hepatic Arterial Infusional Therapy

  2019cites this paper
• Conversion of Unresectable to Resectable Liver Metastases from Colorectal Carcinoma Using Hepatic Arterial Chronomodulated Chemotherapy: A Case Report and Short Literature Review

  2018cites this paper
• Indications for Locoregional Tumor Therapies: CRC Liver Metastases

  2018cites this paper
• Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity.

  2018cites this paper
• Local Treatment Options for Unresectable Liver Metastases in Colorectal Cancer

  2018cites this paper